| For: | Rafaqat S, Rafaqat S. Role of IL-2/IL-2 receptor in pathogenesis of autoimmune disorders: Genetic and therapeutic aspects. World J Med Genet 2023; 11(3): 28-38 [DOI: 10.5496/wjmg.v11.i3.28] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3184/full/v11/i3/28.htm |
| Number | Citing Articles |
| 1 |
Che Ghazali Norul Hajar, Hisham Atan Edinur, Citra Manela, Fika Tri Anggraini. DNA in Health, Identity, and Ancestry. 2026; : 399 doi: 10.1016/B978-0-443-33947-9.00027-X
|
| 2 |
Fatemeh Rangani, Mohammad Ali Nahayati, Majid Pahlevan Kakhki, Seyed Hamid Aghaee-Bakhtiari. Ocrelizumab modulates the IL-2 signaling pathway and associated lncRNAs in multiple sclerosis. Journal of the Neurological Sciences 2026; 480: 125693 doi: 10.1016/j.jns.2025.125693
|
| 3 |
Maryam Masoumi, Mahdi Solaymani, Mitra Abbasifard, Sheyda Houshmandfar, Parnia Iravani, Ali Saeedi-Boroujeni, Jafar Karami. The genetic puzzle of rheumatoid arthritis: Causes, progression, and treatment. Biochemistry and Biophysics Reports 2025; 43: 102148 doi: 10.1016/j.bbrep.2025.102148
|
| 4 |
Chantal Hof, Adrian Angenendt, Sandra Janku, Lukas Jarzembowski, Kathleen Seelert, Dorina Zöphel, Markus Hoth, Annette Lis. Elderly female CTLs maintain their initial activation and cytotoxicity independent of IL-2. Immunity & Ageing 2025; 22(1) doi: 10.1186/s12979-025-00546-4
|
| 5 |
Morteza Rajabi, Sajjad Shafaeibajestan, Sevda Asadpour, Ghazal Alyari, Niloofar Taei, Moein Kohkalani, Ramin Raoufinia, Hamed Afarande, Ehsan Saburi. Primary Progressive Multiple Sclerosis: New Therapeutic Approaches. Neuropsychopharmacology Reports 2025; 45(3) doi: 10.1002/npr2.70039
|
